Logo image of MGRX

MANGOCEUTICALS INC (MGRX) Stock Analyst Earnings Estimates

NASDAQ:MGRX - Nasdaq - US56270V2051 - Common Stock - Currency: USD

2.95  -0.04 (-1.34%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
MGRX revenue by date.MGRX revenue by date.
8.94K731.49K
8,082.21%
EBITDA
YoY % growth
MGRX ebitda by date.MGRX ebitda by date.
-17.52K-1.988M
-11,245.43%		-9.194M
-362.54%
EBIT
YoY % growth
MGRX ebit by date.MGRX ebit by date.
-17.52K-1.992M
-11,267.47%		-9.219M
-362.89%
Operating Margin
MGRX operating margin by date.MGRX operating margin by date.
N/A-22,277.18%-1,260.29%
EPS
YoY % growth
MGRX eps by date.MGRX eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
MGRX Yearly EPS VS EstimatesMGRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 133.37K
-45.60%		%
Q2 2024
Q2Q % growth		 163.16K
15.52%		%
Q1 2024
Q2Q % growth		 214.1K
112.57%		%
Q4 2023
Q2Q % growth		 244.37K
2,633.45%		%
MGRX Yearly Revenue VS EstimatesMGRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 200K 400K 600K
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A